Artefactual nanoparticle activation of the inflammasome platform: In vitro evidence with a nano-formed calcium phosphate

Nanomedicine

Volumn 10, Issue 9, 2015, Pages 1379-1390

  Pele, Laetitia ^a   Haas, Carolin T ^a   Hewitt, Rachel ^a   Faria, Nuno ^a   Brown, Andy ^b   Powell, Jonathan ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

apatite; caspase 1; experimental conditions; IL 1 ; inflammasome; nanoparticle

Indexed keywords

APATITE; APATITIC CALCIUM PHOSPHATE NANOPARTICLE; CALCIUM CHLORIDE; CALCIUM PHOSPHATE; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; NANOPARTICLE; TISSUE CULTURE MEDIUM; UNCLASSIFIED DRUG;

ARTICLE; AXENIC CULTURE; CELL DEATH; CELLULAR SECRETION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; NANOTOXICOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ZETA POTENTIAL; ARTIFACT; DRUG EFFECTS; TRANSMISSION ELECTRON MICROSCOPY;

APATITES; ARTIFACTS; HUMANS; IN VITRO TECHNIQUES; INFLAMMASOMES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES;

EID: 84929870224     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.58     Document Type: Article

References (44)

1. Nel AE, Madler L, Velegol D et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8(7), 543-557 (2009).
2. Powell JJ, Faria N, Thomas-McKay E, Pele LC. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J. Autoimmun. 34(3), 226-233 (2010).
3. Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 7(12), 779-786 (2012).
4. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440(7081), 237-241 (2006).
5. Demento SL, Eisenbarth SC, Foellmer HG et al. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27(23), 3013-3021 (2009).
6. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320(5876), 674-677 (2008).
7. Peng HH, Wu CY, Young D et al. Physicochemical and biological properties of biomimetic mineralo-protein nanoparticles formed spontaneously in biological fluids. Small 9(13), 2297-2307 (2013).
8. Rock KL, Kataoka H, Lai JJ. Uric acid as a danger signal in gout and its comorbidities. Nat. Rev. Rheumatol. 9(1), 13-23 (2013).
9. Vaine CA, Patel MK, Zhu J et al. Tuning innate immune activation by surface texturing of polymer microparticles: the role of shape in inflammasome activation. J. Immunol. 190(7), 3525-3532 (2013).
10. Winter M, Beer HD, Hornung V, Kramer U, Schins RP, Forster I. Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells. Nanotoxicology 5(3), 326-340 (2011).
11. Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13(6), 397-411 (2013).
12. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 10(3), 241-247 (2009).
13. Dorozhkin SV. Bioceramics of calcium orthophosphates. Biomaterials 31(7), 1465-1485 (2010).
14. Ea HK, Chobaz V, Nguyen C et al. Pathogenic role of basic calcium phosphate crystals in destructive arthropathies. PLoS ONE 8(2), e57352 (2013).
15. Jin C, Frayssinet P, Pelker R et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc. Natl Acad. Sci. USA 108(36), 14867-14872 (2011).
16. Pazar B, Ea HK, Narayan S et al. Basic calcium phosphate crystals induce monocyte/macrophage IL-1beta secretion through the NLRP3 inflammasome in vitro. J. Immunol. 186(4), 2495-2502 (2011).
17. Evans SM, Ashwood P, Warley A, Berisha F, Thompson RP, Powell JJ. The role of dietary microparticles and calcium in apoptosis and interleukin-1beta release of intestinal macrophages. Gastroenterology 123(5), 1543-1553 (2002).
18. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519-550 (2009).
19. Juhasz JA, Best SM, Auffret AD, Bonfield W. Biological control of apatite growth in simulated body fluid and human blood serum. J. Mater. Sci. Mater. Med. 19(4), 1823-1829 (2008).
20. Gustavsson J, Ginebra MP, Engel E, Planell J. Ion reactivity of calcium-deficient hydroxyapatite in standard cell culture media. Acta Biomater. 7(12), 4242-4252 (2011).
21. Bilton M, Milne SJ, Brown AP. Comparison of hydrothermal and sol-gel synthesis of nano-particulate hydroxyapatite by characterisation at the bulk and particle level. Open J. Inorgan. Nonmetallic Materials 2(1), 1-10 (2012).
22. Van Der Houwen JaM, Cressey G, Cressey BA, Valsami-Jones E. The effect of organic ligands on the crystallinity of calcium phosphate. J. Cryst. Growth 249(3-4), 572-583 (2003).
23. Berry EE, Leach SA. The structure of some calcium deficient apatites. Arch. Oral Biol. 12(1), 171-174 (1967).
24. Raynaud S, Champion E, Bernache-Assollant D, Thomas P. Calcium phosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation and thermal stability of powders. Biomaterials 23(4), 1065-1072 (2002).
25. Cassel SL, Sutterwala FS. Sterile inflammatory responses mediated by the NLRP3 inflammasome. Eur. J. Immunol. 40(3), 607-611 (2010).
26. Fleshner M. Stress-evoked sterile inflammation, danger associated molecular patterns (DAMPs), microbial associated molecular patterns (MAMPs) and the inflammasome. Brain Behav. Immun. 27(1), 1-7 (2013).
27. Galliher-Beckley AJ, Lan LQ, Aono S, Wang L, Shi J. Caspase-1 activation and mature interleukin-1beta release are uncoupled events in monocytes. World J. Biol. Chem. 4(2), 30-34 (2013).
28. Laliberte RE, Perregaux DG, McNiff P, Gabel CA. Human monocyte ATP-induced IL-1 beta posttranslational processing is a dynamic process dependent on in vitro growth conditions. J. Leukoc. Biol. 62(2), 227-239 (1997).
29. Netea MG, Nold-Petry CA, Nold MF et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113(10), 2324-2335 (2009).
30. Moghimi SM, Andersen AJ, Ahmadvand D, Wibroe PP, Andresen TL, Hunter AC. Material properties in complement activation. Adv. Drug Deliv. Rev. 63(12), 1000-1007 (2011).
31. Laudisi F, Spreafico R, Evrard M et al. Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1beta release. J. Immunol. 191(3), 1006-1010 (2011).
32. Caicedo MS, Samelko L, McAllister K, Jacobs JJ, Hallab NJ. Increasing both CoCrMo-alloy particle size and surface irregularity induces increased macrophage inflammasome activation in vitro potentially through lysosomal destabilization mechanisms. J. Orthop. Res. 31(10), 1633-1642 (2013).
33. Morishige T, Yoshioka Y, Inakura H et al. The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture. Biomaterials 31(26), 6833-6842 (2010).
34. Morishige T, Yoshioka Y, Tanabe A et al. Titanium dioxide induces different levels of IL-1beta production dependent on its particle characteristics through caspase-1 activation mediated by reactive oxygen species and cathepsin B. Biochem. Biophys. Res Commun. 392(2), 160-165 (2010).
35. Mahamid J, Sharir A, Gur D, Zelzer E, Addadi L, Weiner S. Bone mineralization proceeds through intracellular calcium phosphate loaded vesicles: a cryo-electron microscopy study. J. Struct. Biol. 174(3), 527-535 (2011).
36. Wang YH, Liu Y, Maye P, Rowe DW. Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes. Biotechnol. Prog. 22(6), 1697-1701 (2006).
37. Asong J, Wolfert MA, Maiti KK, Miller D, Boons GJ. Binding and cellular activation studies reveal that Toll-like receptor 2 can differentially recognize peptidoglycan from Gram-positive and Gram-negative bacteria. J. Biol. Chem. 284(13), 8643-8653 (2009).
38. Hewitt RE, Pele LC, Tremelling M, Metz A, Parkes M, Powell JJ. Immuno-inhibitory PD-L1 can be induced by a peptidoglycan/NOD2 mediated pathway in primary monocytic cells and is deficient in Crohn's patients with homozygous NOD2 mutations. Clin. Immunol. 143(2), 162-169 (2012).
39. Iyer JK, Coggeshall KM. Cutting edge: primary innate immune cells respond efficiently to polymeric peptidoglycan, but not to peptidoglycan monomers. J. Immunol. 186(7), 3841-3845 (2011).
40. Narayan S, Pazar B, Ea HK et al. Octacalcium phosphate crystals induce inflammation in vivo through interleukin-1 but independent of the NLRP3 inflammasome in mice. Arthritis Rheum. 63(2), 422-433 (2011).
41. Smythies LE, Sellers M, Clements RH et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115(1), 66-75 (2005).
42. Cassel SL, Eisenbarth SC, Iyer SS et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl Acad. Sci. USA 105(26), 9035-9040 (2008).
43. Hornung V, Bauernfeind F, Halle A et al. Silica crystals and aluminium salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9(8), 847-856 (2008).
44. Sandberg WJ, Lag M, Holme JA et al. Comparison of non-crystalline silica nanoparticles in IL-1beta release from macrophages. Part. Fibre Toxicol. 9, 32 (2012).